A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC
Clinical trial NCT06913218 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06913218
- Sponsor
- Akeso
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-22
- Primary completion
- 2028-02-23
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.